Building windmills: How industry leaders plan to embrace tech and innovation trends
Exploring key insights and perspectives from Deloitte's 2025 Life Sciences Outlook
"When the winds of change blow, some people build walls and others build windmills."
Technology advancements, regulatory updates, and a patient-centered focus are driving clinical trial design and conduct towards a period of rapid innovation. The Deloitte 2025 Life Sciences Outlook explores these trends, sharing insightful perspectives from across the industry and revealing why strategic prioritization is crucial for keeping pace and powering growth.
Among 150 executives surveyed, 75% expressed optimism about the future, underscoring a focus on strategy and investment in digital innovations. Notably, 60% identified generative AI and transformative technologies as key trends to monitor closely.
Industry focus for 2025
Across pharmaceuticals, biotechnology and beyond, executives spoke of a focus on adaptability, creating value, and enhancing digital capabilities. The Deloitte report highlights how digital transformation and shifting customer expectations are fueling change, with planning and strategic implementation recognized as a key driver for companies to successfully differentiate. The identified trends included:
1. Technological Integration
Digital technologies are revolutionizing data management, patient engagement, and operational efficiency. From advanced analytics to AI and machine learning, companies plan to leverage these tools to streamline processes and extract insights from complex datasets. Nearly 60% of executives plan to increase generative AI investments to enhance productivity and reduce costs, with 31% investing in transformative technologies.
2. Regulatory Evolution
Regulatory frameworks are evolving to accommodate technological advancements. Adaptive trial designs and the use of real-world evidence are becoming central to accelerating approvals while maintaining patient safety and trial integrity.
3. Patient-Centricity
A renewed focus on patient experiences is reshaping trial designs. Sponsors are considering how to deliver improved patient access to information, support services, and data - before, during and after their participation in clinical trials. Personalized medicine, digital recruitment tools, and real-time feedback loops foster stronger engagement and better retention. By incorporating patient voices into protocols, sponsors can optimize outcomes while improving recruitment timelines. 36% of respondents plan to invest in enhancing customer experiences, engagement and trust.
Delivering Transformative Solutions
Deloitte’s findings emphasize the need for solutions that improve efficiency, enhance engagement, and integrate data effectively. Teckro addresses these gaps with an interconnected, data-driven platform designed to simplify processes, empower users, and accelerate clinical trial outcomes:
- Enhanced Site Engagement: Teckro is purpose-built to generate market-leading site engagement, driving site performance and improved study outcomes. Our solution centralizes communications, study documents, and data in one place, offering anytime study access for site staff - and critical oversight for sponsors. This empowers productivity and supports growth in high-recruiting sites, while strengthening sponsor-site relationships. Best practice studies on Teckro see repeat, monthly engagement from over 70% of sites - up to 7 times higher than traditional approaches.
- Data-Driven Performance: Real-time analytics allow sponsors to monitor and improve site engagement - a leading indicator of performance. By combining engagement metrics with recruitment data, sponsors can segment their sites, enabling targeted performance interventions. Teckro’s predictive analytics highlight potential issues before they escalate, helping sponsors stay ahead of bottlenecks.
- Operational Efficiency: By digitizing protocols, centralizing study communications and integrating workflows, Teckro equips sites for success and sponsors with the visibility and tools to drive improved performance. Proactive, real-time data ensures faster, better-informed responses to trial dynamics - optimizing spend, reducing time to Last Patient In (LPI) and accelerating trial timelines.
Data-Led Trial Management
Our latest webinar explores a fresh approach to measuring and managing performance - particularly with low or non-recruiting sites. Our speakers demonstrate how leading indicators of site engagement unlock value from your recruitment metrics, feeding targeted interventions that reduce time to LPI and optimize spend.
Leading the way
Pairing a strategic approach with the right technologies will redefine how trials are conducted. The report findings show that nearly 60% of executives plan to focus on performance improvement initiatives. Teckro’s data-driven approach exemplifies the shift toward purpose-built, intuitive solutions. By focusing on seamless communication, actionable insights, and user-centric design, sponsors can foster trust with site staff while driving performance, achieving measurable ROI.
Visit our features page to explore the Teckro solution, including our gen-AI enabled FAQ Copilot, premium digital experience and advanced suite of data analytics dashboards.
See it in Action
Ready to reimagine site performance? Teckro is redefining how sponsors approach trial conduct, with a profound shift in resulting study outcomes.
When it comes to bottom line ROI, partnered sponsors reduce time to LPI, make faster, better-informed site continuation decisions and optimize spend.
Take 30 minutes - Meet with our experts to discuss the measurable performance improvements possible for your study. Teckro offers a low barrier to entry with configuration to data in just 4 weeks.
Request a demo
Step 1 of 3
